Recent News

By Category: Countermeasures

Complacency, lack of funds weaken US defense against bioterrorism

(Newsworks.org) A new report from the Trust for America’s Health and the Robert Wood Johnson Foundation includes first-person accounts from public health professionals about responding to 9/11 and the anthrax attacks of 2001. A decade later, the report calls complacency the biggest threat to bioterrorism preparedness. Over the years, steps have been taken to prepare Read More »

September 2, 2011
| Filed under North America, Countermeasures, and Policy & Initiatives
Share

Issues Before the 7th Biological Weapons Review Conference

(Institute for Defence Studies and Analyses) Russia pursued a bio-weapons programme during and after the end of the Cold War. So did Iraq. Although the Convention provides for an approach to the UNSC to carry out investigations, this provision has not been invoked so far. …

August 31, 2011
| Filed under Africa, Asia/Pacific, Europe, Middle East, North America, South America, South Asia, Biological Weapons, Countermeasures, International, and Policy & Initiatives
Share

The Smallpox Vaccination Program: Public Health in an Age of Terrorism

This report discusses lessons learned from the smallpox vaccination program, concludes that there is a need to balance scientific communication with national security imperatives in the context of such programs, and recommends that smallpox preparedness should be comprehensively assessed.

August 30, 2011
| Filed under North America, Bioterrorism, Countermeasures, and Public Health
Share

NIH May Grant Licenses to Produce Anthrax Vaccine

(Occupational Health & Safety) The National Institutes of Health announced that it may grant of an exclusive license to practice the inventions in several patent applications involving anthrax vaccines to Biologics Resources LLC, which is located in Boyds, Md. The patent rights in …

August 30, 2011
| Filed under North America, Biotechnology, and Countermeasures
Share

Results of Emergent BioSolutions Phase 1a Study on Adjuvanted BioThrax Anthrax …

Emergent BioSolutions Inc. announced today that results from a Phase 1a clinical trial evaluating an investigational anthrax vaccine, Anthrax Vaccine Adsorbed with CPG 7909 Adjuvant mixed at bedside, …